ArticleJournal of translational medicine2025

Tumor marker-guided precision BNCT for CA19-9-positive cancers: a new paradigm in molecularly targeted chemoradiation therapy.

Noriyuki Kanehira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.